What's Happening?
One Biosciences, a Paris-based startup backed by Institut Curie, is establishing its first U.S. location in Albany, New York. The company plans to set up a high-complexity lab and computational analytics operation, supported by up to $525,000 in performance-based
tax credits from Empire State Development. This expansion is expected to create 42 life science jobs and involve $18 million in investments over the next five years. One Biosciences aims to leverage its proprietary single-cell profiling technology to address unmet clinical and scientific needs in characterizing the tumor ecosystem. The company's presence in Albany will enhance collaboration with pharma, biotech, and academic partners, benefiting physicians and patients through advanced AI-driven technologies.
Why It's Important?
The establishment of One Biosciences in Albany underscores the growing importance of AI and single-cell technologies in advancing life sciences research. This move aligns with New York's strategic efforts to attract cutting-edge companies and foster innovation in the life sciences sector. The company's focus on characterizing the tumor ecosystem could lead to significant breakthroughs in cancer research and treatment, potentially improving patient outcomes. The investment in Albany also highlights the region's potential as a hub for life sciences innovation, attracting talent and fostering economic growth.
